GTLS

Chart IndustriesF

NYSE / Capital Goods

At close

2026-06-02

Current thesis

Chart converts a large portion of its hydrogen backlog within 12–24 months, supply-chain pressures ease, margins recover, and biopharma/LNG mix expands—making the consensus ~$55 target conservative relative to multi-year revenue visibility [#PR-2025-08-12], [#IR-presentation-Q3-2025].

Posture

Defensive

Lead driver

Value

What changed

Value remains the lead driver in the composite, 7D delta -0.1.

What can break

Project delays, cost overruns, or cancellations push revenue recognition out and compress margins; weaker hydrogen capex or incentive setbacks could force a multiple re-rating until execution is proven [#10-Q-2024-06-30], [#PR-2025-11-05].

Momentum

Value

Sentiment

Setup hits (3d)

0 · Net Neutral

AI TargetsBase $55.00 · Bull $68.75 · Bear $38.25

Data freshness

Prices

As of 2026-06-02

Fundamentals

As of 2026-06-01 • Vendor: Data Vendor v1

Scores

As of 2026-06-02 • Model: HYBRID_IC_RP

AI Memo

As of 2025-11-14 • Model: RankAlpha Sentiment AI

Investment thesis

As of 2026-06-02

Supporting evidence

What

Grade F · Defensive

Confidence Medium · Net Neutral

Target $210.40

Why

Momentum40 · Δ7d -1.7

Value58 · Δ7d -0.1

Sentiment0 · Δ7d 0.0

So what

Weak posture (Net Neutral). Prioritize risk control and patience.

Lead driver: Value · See fundamentals

Momentum

34% active weight

Current posture

7d trendFlat

Δ7d

-1.7

Δ21d

+12.4

Value

32% active weight

Current posture

7d trendFlat

Δ7d

-0.1

Δ21d

-0.1

Sentiment

33% active weight

Current posture

7d trendFlat

Δ7d

0.0

Δ21d

0.0

Why this grade

Composite grade F. Momentum 39.9 / Value 57.8 / Sentiment 0.0

Fundamentals (TTM)

As of 2026-06-01

Market Cap

$9.95B

Beta

1.75

Shares Out

44.95M

P/E (TTM)

232.0

P/S (TTM)

2.16

P/FCF (TTM)

25.03

Rev YoY

+3.6%

EPS YoY

-341.0%

Gross Margin

+33.8%

Op Margin

+9.8%

Net Debt

$3.35B

Current Ratio

1.40

As of 2026-06-02 • Updated nightlySource: Internal modelMethodology